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ABSTRACT 
Action of Manganese on Puberty. (May 2007) 
Bo Yeon Lee, B.S., Chonnam National University 
Chair of Advisory Committee: Dr. W. Les Dees 
 
 
Manganese (Mn) is considered important for normal growth and reproduction. 
Because Mn can cross the blood brain barrier and accumulate in the hypothalamus, and 
because it has been suggested that infants and children are potentially more sensitive to 
Mn than adults, we wanted to determine the effects of Mn exposure on puberty-related 
hormones and the onset of puberty, and discern the site and mechanism of Mn action.  
We demonstrated that the central administration of manganese chloride (MnCl2) 
stimulated luteinizing hormone (LH) release in prepubertal rats. Incubation of medial 
basal hypothalamus (MBH) in vitro showed this effect was due to a Mn-induced 
stimulation of luteinizing hormone releasing hormone (LHRH). Further demonstration 
that this is a hypothalamic site of action was shown by in vivo blockade of LHRH 
receptors and the lack of a direct pituitary action of Mn to stimulate LH release in vitro. 
Chronic supplementation of low dose of MnCl2 caused elevated serum levels of LH, 
follicle stimulating hormone (FSH) and estradiol or testosterone. Importantly, Mn 
supplementation advanced the timing of puberty in both sexes. 
We investigated the mechanism by which Mn induces LHRH/LH release from 
the hypothalamus. Blocking the NMDA receptor, IGF1 receptor, or inhibiting nitric 
oxide synthase in vivo was ineffective in altering Mn-induced LH release. Dose-
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response, pharmacological blockade and nitrite assessments indicated that the lowest 
doses of Mn used stimulated LHRH release, but did not induce nitric oxide (NO) 
production, while only the highest dose of Mn stimulated NO. Conversely, a dose-
dependent inhibition of Mn-induced LHRH release was observed in the presence of 
ODQ, a specific blocker of soluble guanylyl cyclase. Furthermore, Mn stimulated the 
release of cyclic GMP (cGMP) and LHRH from the same MBH, and a protein kinase G 
(PKG) inhibitor, KT5823, blocked Mn-induced LHRH release.  
Collectively, these data demonstrate that Mn can stimulate specific puberty-
related hormones both acutely and chronically, and furthermore, suggest that low levels 
of Mn facilitate the normal onset of puberty. The principal action of Mn within the 
hypothalamus is to facilitate the activation of guanylyl cyclase, which subsequently 
stimulates the cGMP/PKG pathway resulting in the stimulation of prepubertal LHRH 
secretion. 
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CHAPTER I 
INTRODUCTION 
 
Manganese (Mn) is a naturally occurring elemental metal that is required for 
normal mammalian physiological processes, including growth and development of bones 
and cartilage (Hurley, 1981), as well as connective tissue and the reproductive system 
(Greger, 1999; Keen et al.,1999). Furthermore, Mn plays roles in metabolic regulation, 
as well as protein and energy metabolism by participating as a catalytic or regulatory 
factor for enzymes. The classes of enzymes that have Mn as a cofactors are very broad 
and include oxidoreductases, transferases, hydrolases, lyases, isomerases, ligases, 
lectins, and integrins (Wedler and Denman, 1984; Keen et al., 2000; Takeda A., 2003).  
Everyday, people are exposed to Mn through food, air, soil, and water. Mn can 
enter the environment from iron, steel, and power plants into air, and from mining 
operations into dust, and natural deposits, disposal of wastes, or deposits from airborne 
sources into the water and soil. This metal is used for various purposes and products 
including batteries, fertilizers, pesticides, ceramics, and dietary supplements. Individuals 
who work in occupations that mine Mn or improperly use pesticides such as maneb and 
mancozeb are likely to be exposed to excess levels through their work environment 
(Gerber et al., 2002). Exposure to methylcyclopentadienyl manganese tricarbonyl 
(MMT), a fuel additive in some gasolines, is another source of exposure (EPA, 2001).  
 
_______________ 
This dissertation follows the style of Toxicological Sciences. 
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Absorption of Mn is affected by an individual’s age, route of exposure, the 
chemical form and to other dietary factors (USEPA, 2002). Intake varies greatly, 
depending mainly on the consumption of rich sources, such as unrefined grains, cereals, 
green leafy vegetables, and tea. The usual oral intake of this mineral is 2 to 5 mg/day, 
and absorption is 5 to 10% (Greger, 1998).  
Both excesses and deficiencies of Mn are known to cause serious health 
problems. Exposure to high levels of airborne manganese can cause Parkinsonism-like 
symptoms (Jankovic, 2005; Calne et al., 1994). Industries associated with manganese 
emissions include ferroalloy production, iron and steel foundries, metal fumes from 
welding, battery production, and power plant and coke oven combustion emissions (Lioy, 
1983). The mechanisms of Mn neurotoxicity have become an important area of concern 
because excesses of this element can cause numerous central nervous system (CNS) 
disorders (Beuter et al., 1994; Pal et al., 1999). Exposure to high levels of the metal also 
can cause respiratory problems and sexual dysfunction (Aschner et al., 2005). 
Conversely, low levels of manganese in the body have been associated with infertility, 
bone malformation, weakness, and seizures (Freeland-Graves and Llanes, 1994; Keen et 
al., 1999). Mn deficiencies are considered rare, since it is relatively easy to obtain 
adequate amounts of manganese through the diet. However, it has been known for a long 
time that Mn deficiencies are associated with impaired growth and reproduction in 
females and males (Boyer, 1942; Smith, 1944), suggesting important roles in these 
processes. 
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Because of its potential role in reproductive function, we questioned whether Mn 
plays a role in adolescent development and the pubertal process. There have been only a 
few studies assessing Mn exposure in immature animals. These studies were not done 
specifically to discern puberty related events and the onset of puberty and used high 
doses of different forms of Mn, and the Mn insult was either removed before the 
peripubertal period or hormones were assessed after castration. Also, the studies were 
conducted before accurate, sensitive luteinizing hormone (LH) assays were available for 
rodents and we could find no attempt to critically discern the actual timing of puberty 
(USEPA, 2002). Preliminary data for this study suggested that low but elevated levels of 
manganese chloride (MnCl2) advanced the onset of puberty, and that this was associated 
with elevated puberty-related hormones. Should Mn levels in brain be elevated even 
moderately at an early age, this may activate luteinizing hormone releasing hormone 
(LHRH) secretion or facilitate an endogenous modulator of LHRH release; therefore, 
placing an individual at risk for a precocious pubertal development.  
Precocious puberty is defined as the onset of puberty before the age of 8 in girls 
and 9 in boys (Lee, 1980). Recently, it has been reported that there has been a trend for 
earlier onset of the puberty. A “true” precocious puberty is due to central causes and 
reflects increased gonadotropins, where as “Pseudo” precocious puberty is due to 
peripheral causes. Central precocious puberty can begin anytime after birth, and is 
hypothalamic LHRH-dependent, and characterized by hormonal changes similar to those 
that occur at the normal time of puberty. The classic changes noted are an increased 
afternoon pulsatile secretion of LH, an increased LH responsiveness to LHRH, and 
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increased gonadal steroid secretion. Thus, in central precocious puberty there is a 
premature activation of the LHRH pulse generator. In boys, such activation is usually 
accounted for by hypothalamic hamartomas, other CNS lesions or familial disease, with 
less than 10% being idiopathic. In girls, however, it is much different with over 65% 
being idiopathic with no identifiable cause. There must be some underlying 
pathophysiological causes and any substance that can act centrally to stimulate LHRH 
release could be involved in the initiation of precocious pubertal development. 
Precocious puberty also places children at risk for not achieving their genetic 
height potential. The rapid maturation of the growth plate will often result in temporary 
acceleration of linear growth, but the accompanying early closure of growth plates 
results in early cessation of growth and ultimately shorter than what would be expected 
for their adult height (Wheeler and Styne, 1990). Precocious puberty can be an early sign 
of metabolic syndrome (syndrome X), obesity, and insulin resistance (Ibanez, 1997; 
Pathomvanich, 2000).  
The possibility exists that Mn is beneficial as an environmental factor that works 
in concert with other substances to facilitate LHRH release at the normal time of puberty. 
Interestingly, if this is the case then it is also possible that an early elevation, especially 
in females, could activate the LHRH releasing system prematurely. This may not 
necessarily mean very high levels, but if Mn accumulates in the brain too early in life 
and reaches levels that normally are not attained until later, then this may actually be 
harmful. Other indicators that support the possibility that Mn may accumulate in brain 
are the observations of high levels of Mn in the drinking water in some regions, concern 
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for high levels in some baby formulas (Lonnerdal et al., 1987), and increased amounts of 
MMT in the air from the gasoline. It may mean that any one of these in excess could be 
harmful, or it could take a combination of low level insults. Infants and children have 
been identified as being potentially more sensitive for excess Mn exposure (USEPA, 
2002). This is largely because the optimum level of oral exposure is not well defined 
(Greger, 1999), some evidence in animals that the young do not yet have full capacity to 
eliminate Mn (Fechter, 1999), and because the tissue accumulation and health effects in 
humans, especially children, are not well understood.  
Mn enters the brain either through cerebral vasculature or via the cerebrospinal 
fluid (CSF). The mechanism of crossing the blood brain barrier (BBB) is not completely 
understood, but likely involves binding of Mn to transport mechanisms such as 
transferrin (Aschner and Aschner, 1990; Aschner, 2000). As blood levels rise, influx into 
CSF increases and entry across the choroid plexus becomes more important (Murphy et 
al., 1991). Brain regions, like the preoptic area (POA) and the hypothalamus, which are 
adjacent to the third ventricle and responsible for LHRH production and secretion, 
respectively receive Mn from both capillaries and CSF. Mn has been shown to cross the 
blood-brain barrier over 4 times more efficiently in young vs. adult animals (Mena, 
1974) and can accumulate in the hypothalamus (Deskin, 1980). This suggests the need to 
further investigate the actions of Mn on the hypothalamic control of the onset of puberty. 
The CNS plays the critical role in bringing together events that lead to the onset 
of puberty by controlling both anterior pituitary function via hypothalamic hormones and 
ovarian function via pituitary hormones and direct neural inputs. The physiological 
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pattern of LH and follicle-stimulating hormone (FSH) secretion is periodic and 
intermittent, although more pronounced for LH. Before the onset of puberty the 
amplitude of release is low and after onset, the release becomes more prominent in the 
afternoon. This basic pattern is similar in both rats and humans (Urbanski and Ojeda, 
1990; Delemarre-Van De Waal et al., 1991) and is a centrally driven event reflective of 
the pulsatile release of hypothalamic LHRH (Knobil, 1980). The current understanding 
is that the pituitary and gonad are capable of function at any age after a short period of 
priming (Lee, 1996). LHRH secretion is minimal during juvenile and childhood 
development and thus, this system is down-regulated; however, when the pulsatile 
frequency and amplitude is enhanced, the onset of puberty begins. The exact signal 
initiating this change in LHRH release is not known, but may be due to removal of an 
inhibitory tone or more likely, to completion of the development or activation of 
excitatory inputs.  
Recently, in rats and primates, activation of a specific class of brain excitatory 
amino acid receptors, namely N-methyl-DL- aspartic acid receptors (NMDA-R; Gay and 
Plant, 1987; Urbanski and Ojeda, 1987), and activation of insulin-like growth factor-1 
receptors (IGF1-R; Hiney et al., 1996; Wilson, 1998) have been shown to stimulate 
LHRH release and advance female puberty. Normally, as puberty approaches the LHRH/ 
LH levels rise, estradiol (E2) increases and the central component of the E2 positive 
feedback on the hypothalamus is enhanced. During this phase there is an increased 
hypothalamic capacity to synthesize prostaglandin E2 (PGE2), a compound known to 
mediate norepinepherine (NE)-induced LHRH release (Ojeda et al., 1979). NE is an 
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important neurotransmitter downstream in the pathway of both IGF-1 receptors and 
NMDA receptors, and appears to participate in the first preovulatory surge of LH 
(Sarkar et al., 1981). E2 not only increases PGE2 production prior to the first surge of 
gonadotropins (Claypool et.al., 2000), but also aids in neuronal growth and maturation 
of synaptic connections (Matsumaoto and Arai, 1977). As E2 levels gradually rise, they 
eventually reach levels high enough to produce the preovulatory LHRH and 
gonadotropin surges and subsequently, first ovulation and reproductive maturity. 
Importantly, the complex events within the hypothalamus that lead to LHRH release and 
puberty appear to require interactive participation of neuronal circuitries and glial 
networks of the hypothalamus (Ojeda, 1994) (Fig. 1.1).  
It has been shown that Mn is capable of permeating the NMDA-R channel 
(Mayer and Westbrook, 1987). Mechanisms of LHRH release after these receptors have 
been activated are not completely worked out; however, downstream from these 
receptors the pathways do appear to share some common functional sites such as the 
presence of nitric oxide synthase/ nitric oxide (NOS/NO), and when the system is 
activated it causes increased PGE2, and finally, LHRH release (Ojeda et al., 1979; 
Rettori et al., 1993; Hiney et al., 1998). When NO diffuses into LHRH terminals it may 
activate guanylyl cyclase which activates the cyclic GMP (cGMP)/protein kinase G 
(PKG) pathway, triggering LHRH secretion. NMDA-R activated LHRH release may 
also utilize the cyclic GMP (cGMP)/protein kinase G (PKG) pathway (Karanth et al., 
2003).  
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Figure 1.1. Schematic drawing of the hypothalamic excitatory inputs controlling LHRH secretion. 
All arrows represent stimulatory actions. IGF-R, insulin-like growth factor receptor; OCT 2, POU 
homeodomain gene; TGFα, transforming growth factor α; EGF-R, epidermal growth factor receptor; 
ARG, arginine; CIT, citruline; NOS, nitric oxide synthase; NO, nitric oxide; EAA, glutamate and aspartate 
neuron; NMDA-R, N-methyl-D, L-aspartic acid receptor;  NE, norepinephrine; α1R, α 1 adrenergic 
receptor; PKG, protein kinase G; COX, cyclooxygenase; PGE2, prostaglandin-E2
 
 
 
It is also possible that Mn could stimulate other components that are beginning to 
emerge as being potentially important for the onset of puberty. In this regard, Mn could 
induce or facilitate expression of the POU homeodomain gene which increases in the 
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female hypothalamus as puberty approaches. This is associated with increased 
hypothalamic content of transforming growth factor-α (TGFα) (Ojeda et al., 1999). 
TGFα binds to the epidermal growth factor-receptor (EGF-R) in the medial basal 
hypothalamus (MBH) and the activation of this receptor results in LHRH release (Ojeda 
et al., 1990; Hiney et al., 2002). Another possibility is for Mn to enhance hypothalamic 
IGF-1 and glutamate, suggesting increased availability of these naturally occurring 
ligands for IGF-1 and NMDA receptors within the POA and medial basal hypothalamus 
(MBH); the sites responsible for synthesis and secretion of LHRH.  
The present study will assess the ability of Mn to contribute to pubertal 
development and will begin to discern mechanisms of Mn action. We hypothesize that 
Mn may precociously activate the reproductive control center in the hypothalamus to 
stimulate the secretion of LHRH; hence initiating the onset of puberty. We will use both 
in vivo and in vitro approaches to identify the hypothalamic site and mechanism of this 
action.  
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CHAPTER II 
MANGANESE ACTS CENTRALLY TO STIMULATE LUTEINIZING 
HORMONE SECRETION: A POTENTIAL INFLUENCE ON FEMALE 
PUBERTAL DEVELOPMENT  
 
INTRODUCTION 
Manganese (Mn) is a naturally occurring elemental metal that is required for 
normal mammalian physiological functions. Both excesses and deficiencies of Mn affect 
brain function and cause serious health problems. Mn is a known cofactor for a variety 
of brain enzymes such as glutamine synthetase and mitochondrial superoxide dismutase 
(Wedler and Denman, 1984), as well as transferases and hydrolases (Wedler, 1993). Mn 
is also necessary for the normal growth and development of bone and cartilage (Hurley, 
1981), connective tissue, and the reproductive system (Greger, 1999; Keen et al., 1999).  
With regard to reproduction, it has been known for many years that Mn 
deficiencies are associated with impaired growth and reproduction in females and males 
(Boyer et al., 1942 ; Smith et al.,1944); hence, suggesting a role in reproductive 
function. While it is known that exposure to high levels of Mn is toxic and causes 
developmental reproductive dysfunction (Gray and Laskey, 1980; Laskey et al., 1982), it 
is not known whether exposure to lower, but still elevated levels of the metal would 
facilitate or inhibit neuroendocrine development of reproductive function. This is 
important since infants and children have been identified as being potentially more 
sensitive to Mn and because the optimum level of oral Mn exposure is not well-
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understood (USEPA, 2002; Greger, 1999). Since Mn has been shown to cross the blood-
brain barrier over four times more efficiently in young vs. adult animals (Mena, 1974), 
and can accumulate in the hypothalamus (Deskin et al., 1980), we hypothesized that it 
may influence the neuroendocrine system prior to puberty. Thus, the present study 
assessed whether this natural environmental metal is involved in the hypothalamic 
control of prepubertal LH secretion, and whether chronic, low dose exposure of the 
metal to prepubertal animals would affect levels of puberty-related hormones and alter 
the timing of female puberty. 
 
MATERIALS AND METHODS 
Immature female rats of the Sprague-Dawley line that were raised in our colony 
at the Texas A&M University Laboratory Animal Facility were used for these 
experiments. The animals were housed under controlled conditions of photoperiod 
(lights on, 0600 hr, lights off, 1800 hr) and temperature (23 ºC), with ad libitum access 
to food and water. The diet was Harlan Teklad 2016 which contained 94.7 mg/kg Mn 
and 149.8 mg/kg iron (Fe) as analyzed by the Heavy Metal Analysis Laboratory, 
Department of Integrative Biosciences, College of Veterinary Medicine, Texas A&M 
University. All procedures used were approved by the University Animal Care and Use 
Committee and in accordance with the NIH Guidelines for the Care and Use of 
Laboratory Animals. 
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Effect of centrally administered Mn on LH secretion  
Twenty-three-day-old female rats were stereotaxically implanted with a stainless 
steel cannula (23 gauge) in the third ventricle (3V) of the brain and allowed five days for 
recovery (Antunes-Rodrigues and McCann 1970). When the rats were 29 days old, 
silastic cannulae were inserted into the right external jugular vein of each rat (Harms and 
Ojeda, 1974). The next day, an extension of tubing was attached to each cannula and 
flushed with heparinized saline (100 IU/ ml). Following a one hour acclimation period, 
three basal blood samples were drawn from each freely moving animal at 15-minute 
intervals. A 3V injection of manganese chloride (MnCl2; 1.0, 2.5, 5.0, 10.0, or 25.0 μg/ 
3.0 μl; Sigma Chemical Company, St. Louis, Mo) or an equal volume of saline 
immediately followed the third basal sample. After the respective injection, four more 
samples were taken for a total of seven samples. After the experiment, brains were 
examined for proper cannula placement, and animals were confirmed to be in the 
juvenile phase of development by criteria we have previously used (Dees and Skelley, 
1990). Blood samples were centrifuged at 4 °C, and serum was stored at –70 °C until 
assayed for LH. 
Effects of Mn on LHRH release from hypothalami in vitro 
The ability of Mn to induce LHRH release directly from the median basal 
hypothalamus (MBH) incubated in vitro was evaluated. In this regard, 30 day old female 
rats were decapitated, the MBH removed, and incubated as described previously (Hiney 
et al., 1999) with minor modifications. Briefly, each MBH was incubated in a vial 
containing 350 µl of Lockes Buffer (2mM Hepes, 154 mM NaCl, 5.6 mM KCl, 1 mM 
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MgCl2, 6 mM NaHCO3, 10 mM glucose, 1.25 mM CaCl2, and 1 mg/ ml BSA pH 7.4) 
inside a Dubnoff shaker (50 cycles/min) at 37 ºC in an atmosphere of 95% O2 and 5% 
CO2 for 30 minutes. This medium was discarded, and all MBH’s were incubated in fresh 
medium for 30 minutes to establish basal LHRH release. The medium was removed, 
boiled for 10 minutes, and stored in microcentrifuge tubes, and replaced with medium 
containing 0, 50, 250, or 500 µM MnCl2. The MBHs were incubated for an additional 30 
minutes. This medium was collected, boiled for 10 minutes, and stored at – 80 ºC until 
assayed for LHRH. MBHs were weighed to the nearest 0.01 mg. 
Effect of LHRH receptor antagonism on Mn-induced LH release 
Third ventricular and external jugular cannulae were implanted as described 
above. The next day, an extension of tubing was attached to each cannula and flushed 
with heparinized saline (100 IU/ml). Half of the animals received a single subcutaneous 
injection of acyline (10 µg), a potent LHRH antagonist which was provided by Dr. H.K. 
Kim, Contraception and Reproductive Health Branch, Center for Population Research, 
National Institute of Child Health and Human Development, Bethesda, MD. The 
remaining animals received an injection of equal volume saline. Following a two hour 
absorption period, three basal blood samples were drawn from each freely moving 
animal at 15-minute intervals. Immediately following the third basal sample, a 3V 
injection of MnCl2 (10 µg) was administered to all of the animals. Then four more 
samples were taken for a total of seven samples. After the experiment, brains were 
examined for proper cannula placement, and animals were confirmed to be in the 
juvenile phase of development by criteria we have previously used (Dees and Skelley, 
 14
1990). Blood samples were centrifuged at 4 °C, and serum was stored at –70 °C until 
assayed for LH. 
Effect of Mn on LH release from pituitary glands in vitro 
Thirty-day-old female rats were decapitated, pituitaries removed, and incubated 
as described previously (Hiney et al., 1999). Briefly, the posterior lobe was removed and 
each anterior pituitary (AP) was incubated in a vial containing 1.0 ml of Krebs-Ringer 
bicarbonate (pH 7.4) containing glucose (4.5 mg/ml) inside a Dubnoff shaker (50 cycles/ 
min) at 37 ºC in an atmosphere of 95% O2 and 5% CO2 for 60 minutes. This medium 
was discarded, and all APs were incubated in fresh medium for 30 minutes to establish 
basal LH release. The medium was removed and stored in microcentrifuge tubes, and 
replaced with medium containing 100 µM MnCl2. The APs were incubated for an 
additional 30 minutes. This medium was collected and stored at – 80 ºC until assayed for 
LH. Pituitaries were weighed to the nearest 0.01 mg.  
Effect of chronic Mn exposure on puberty-related hormones and the onset of 
female puberty  
Litters were adjusted to 8-11 pups with at least 5-6 females per litter. In the first 
experiment, MnCl2 (0.25 mg in 0.2 ml/25 g rat) or an equal volume of saline was 
administered daily by a single gastric gavage injection from day 12 until day 29, at 
which time the rats were killed by decapitation and blood collected for hormonal and Mn 
assessments. A second experiment was conducted exactly as above except that the 
animals continued to be dosed with MnCl2 until VO occurred. This Mn dose caused a 
cumulative intake of 9.7 mg of Mn over the entire dosing period. Oral Mn intake is 
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absorbed at about 5% and therefore, this dose and method resulted in approximately 0.49 
mg of Mn absorbed during the 17 day period. Since the Mn-treated rats were about 100 
grams body weight at this time (~ 32 days of age) this means they absorbed a total of 
approximately 4.9 mg Mn/kg animal. 
Hormone analysis 
Rat LH and follicle-stimulating hormone (FSH) were measured using 
radioimmunoassay (RIA) procedures as previously described (Hiney et al., 1996). The 
rat LH antiserum (NIDDK-anti-rLH-S-II), antigen (NIDDK-rLH-I-9), reference 
preparation (NIDDK-rLH-RP-3), FSH antiserum (NIDDK-rFSH-I-9), and reference 
preparation (NIDDK-rFSH-RP-2) were purchased from the NIH Pituitary Hormones & 
Antisera Center, Harbor-UCLA Medical Center, Torrance, California. The LH assay had 
a sensitivity of 0.07 ng/ml and the FSH assay had a sensitivity of 0.4 ng/ml. Serum 
estradiol (E2) was measured by an RIA kit purchased from Diagnostic Products Corp. 
(Los Angeles, California) as we have previously described (Hiney et al., 1996). The E2 
assay sensitivity was 8.0 pg/ml. All assays had inter- and intra-assay coefficients of 
variation of < 10%. The LHRH was measured as previously described (Hartter and 
Ramirez, 1985) using Antisera N0.R11B73 kindly provided by Dr. V.D. Ramirez. 
Synthetic LHRH used for the standards and iodinations was purchased from Sigma 
Chemical Co (St. Louis, MO). The sensitivity of the assay was 0.2 pg/ tube, and the 
intraassay coefficient of variation was < 10%. 
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Metal analysis 
Mn was measured by the heavy metal analysis lab, Department of Integrative 
Biosciences, College of Veterinary Medicine, Texas A&M University. A Perkin-
Elmer/Sciex DRC II inductively coupled plasma-mass spectrometer was used. Tissue 
digestion followed the method of da Silva et al. (1998) with the following modifications. 
20-40 mg of wet tissue sample and QA/QC samples (SRM, spiked samples, sample 
duplicates, blank, and blank spike) were digested with 200 µl of H2O2 and 100 µl of HCl 
at 90˚C for 6 hours. The volume was then brought up to 10 ml. The method was 
considered in control when the SRMs, spike recoveries, and duplicates were ± 15% of 
the expected value and blank values were < 0.001 ppb.  
Statistical analysis 
All values are expressed as the mean (± SEM). Differences between treatment 
groups were analyzed either by Student’s t test or by Kruskal-Wallis nonparametric 
analysis of variance (ANOVA) followed by post hoc testing using Dunn’s multiple 
comparisons test. P-values less than 0.05 were considered significant. The IBM PC 
programs INSTAT and PRISM (GraphPad, San Diego, California) were used to 
calculate and graph the results. 
 
RESULTS 
Effect of centrally administered Mn on LH secretion 
Central administration of Mn stimulated LH release significantly and dose 
dependently over basal levels (Fig. 2.1). Animals that received saline or the 1.0 µg dose 
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of Mn exhibited no change in LH released as compared to their respective basal levels. 
However, animals that received 2.5, 5 and 25 µg doses of MnCl2 exhibited 3- 18- and 
33-fold increases in LH release, respectively, compared with basal levels. We suggest 
that this is a hypothalamic site of action, and the effect is exerted by very low doses 
since the Mn is further diluted by cerebrospinal fluid in the 3V and because only some of 
the Mn diffuses into the basal hypothalamus to apparently induce LHRH secretion.  
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Figure 2.1. The effect of 3V administration of Mn on LH release during the late juvenile phase of 
developing female rats.  
Each concentration point indicates basal LH levels vs. stimulated levels. The animals which received the 
saline and the 1.0 µg dose of Mn showed no significant changes in LH secretion when compared to basal 
levels. However, animals which received 2.5 µg, 5.0 µg, and 25 µg doses of Mn showed marked increases 
in LH secretion when compared to their respective basal levels. Values represent mean ± SEM, and the 
number of animals is depicted within each panel (*, P < 0.05; **, P < 0.01; ***, P < 0.001). 
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Effect of Mn on LHRH release from hypothalami in vitro 
Because LHRH cannot be measured accurately in serum, in vitro studies using 
the MBH were conducted. The MBH was removed from 29 day old female rats and 
incubated with three different concentrations of Mn. The addition of Mn to the challenge 
medium stimulated the release of LHRH in a dose dependent fashion as compared to 
basal levels (Fig. 2.2). MBHs incubated in Locke’s Buffer without Mn showed no 
change between incubation and challenge levels while those incubated in the 50 (P < 
0.05), 250 (P < 0.02), and 500 uM (P < 0.05). Mn demonstrated a marked increase in the 
amount of LHRH released. 
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Figure 2.2. The effect of MnCl2 on LHRH release from the medial basal hypothalamus in vitro. 
Each concentration point indicates basal LHRH levels vs. stimulated levels. Tissue incubated in Lockes 
buffer only showed no significant changes in LHRH secretion when compared to basal levels. Tissues 
incubated in 50 µM, 250 µM, and 500 µM concentrations of Mn showed significant increases in LHRH 
secretion when compared to their respective basal levels. Values represent mean ± SEM. The number of 
samples is depicted within each panel (*, P < 0.05; +, P < 0.02). 
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Effect of LHRH receptor antagonism on Mn-induced LH release 
To further support that the Mn acted at the level of the hypothalamus and not the 
pituitary animals were treated with the LHRH receptor antagonist, acyline, prior to Mn 
administration. The 10 ug dose of Mn injected directly into the third ventricle of the non- 
acyline treated animals markedly stimulated LH release over basal levels (.37± .03 vs. 
1.7 ± .5). However, animals pre-treated with acyline showed no significant change in LH 
levels after the Mn was administered (.35 ± .04 vs. .57 ± .02) (Fig. 2.3).   
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Figure 2.3. The effect of pretreatment with the LHRH receptor antagonist, acyline, on MnCl2 
stimulated LH release.  
Acyline treated animals showed no significant change in LH release after 3V administration of MnCl2 as 
compared to basal levels. Animals which were not pretreated with acyline exhibited a four-fold increase in 
LH as compared to basal levels (**, P < 0.01). Values represent the mean ± SEM. The number of animals 
is depicted within each panel. 
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Effect of Mn on LH release from pituitary glands in vitro 
In vitro incubation of hemipituitaries with 100 µM Mn indicated that Mn was 
incapable of stimulating LH from the pituitary gland directly. In this regard basal levels 
of secreted LH were 16.9 ± 2.4 ng/mg, and LH levels after a 30 minute incubation with 
manganese were 14.7 ± 6.8 ng/mg (n = 13), further suggesting a hypothalamic action. 
Effect of chronic Mn exposure on puberty related hormones and the onset of 
female puberty 
Chronic exposure to a low dose of Mn during juvenile development caused 
increases in specific puberty-related hormones. In this regard, the serum levels of LH, 
FSH and E2 were all elevated (P < 0.05) by 29 days of age in Mn-treated vs. control 
animals (Fig. 2.4). The dose and regimen of Mn administration produced an 
accumulation of Mn in the brain, resulting in elevated Mn levels in both the preoptic 
area (P < 0.02) and the MBH (P < 0.05) when compared to controls (Fig. 2.5). As 
expected, serum Mn levels were not different from the controls at the time of blood 
collection (not shown) since a very low oral dose of Mn was used, and the rats did not 
receive the dosage on the final day of the experiment. When the dosing regimen was 
continued for several more days to assess the timing of puberty, we observed that 
chronic Mn exposure did not alter mean (± SEM) daily weight gain (controls, 3.8 ± 0.07 
gm/day; Mn-treated, 3.7 ± 0.08 gm/day), but advanced (P < 0.001) the age at VO 
compared with saline controls. Specifically, mean (± SEM) VO was 32.8 ± 0.21 days 
compared with 34.3 ± 0.22 days in the controls (Fig. 2.6), a 1.5 day advancement in the 
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onset of puberty that appears to be moderate in terms of time, but a highly significant 
trend.  
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Figure 2.4. Effect of chronic oral administration of MnCl2 on puberty related hormones in 29 day 
old female rats.  
(A-C) serum levels of LH (A), FSH (B), and E2 (C). Values represent the mean ± SEM, and the number of 
animals is depicted within each bar (*, P < 0.05 vs. control). 
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Figure 2.5. Accumulation of Mn in brain after chronic oral administration. 
Daily administration of MnCl2 at 10mg/kg increased Mn levels in both the MBH and the POA by 33% (*, 
P < 0.05; **, P < 0.01). Values represent the mean (n = 8) ± SEM. 
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Figure 2.6. Effect of chronic oral administration of MnCl2 on the age at vaginal opening (VO). 
Note that low level Mn exposure during the juvenile period moderately advanced the age at VO in terms 
of days (1.5 days), yet this was a highly significant trend. Values represent the mean ± SEM, and the 
number of animals is depicted within each bar (***, P < 0.001). 
 
 
 
DISCUSSION 
The results of this study are the first to show a stimulatory action of Mn on the 
hypothalamic control of prepubertal gonadotropin secretion, and the ability of chronic, 
low dose Mn exposure to moderately accelerate the onset of female puberty. The dose 
used for the chronic studies was low compared to previous studies using rats, and is 
comparable on a mg/kg basis to that which has been shown to have effects on effortful 
response tests in adult primates (Newland and Weiss, 1991). Although different 
endpoints were assessed, the low level effect of Mn we described is important since 
many of the detrimental, neurotoxicological endpoint effects of the metal in adult rats 
and primates occurred after much higher doses (Newland, 1999). The fact that the low 
dose of Mn used in the present study facilitated specific puberty-related events, such as 
increased gonadotropins and estradiol, may be of importance for understanding the 
control of the onset of female puberty and furthermore, under certain circumstances it 
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may be possible that this seemingly beneficial effect could be harmful. In this regard, we 
suggest that a Mn-induced activation of the LHRH releasing system early in childhood 
may place an individual at risk for precocious pubertal development.  
The age at which the normal onset of puberty begins is variable and depends on a 
complex series of events within the hypothalamus that culminates in the increased 
secretion of LHRH. This increase appears to require interactive participation of neuronal 
circuitries and glial cells within the hypothalamus (Ojeda and Urbanski, 1994), which 
are likely influenced by metabolic signals of peripheral origin, as well as genetic and 
environmental influences (Parent et al., 2003). Despite the normal variation in the timing 
of puberty, in recent years there has been evidence presented that suggests puberty, 
especially in females, may be occurring at an earlier age (Herman-Giddens et al., 1997; 
Parent et al., 2003). At the present time the cause of this trend is not known, but it has 
been suggested that assessing the onset of puberty may be a sensitive marker of 
interactions between environmental conditions and genetic susceptibility that may 
influence the pubertal process (Parent et al., 2003).  
The onset of puberty before age 8 in girls and 9.5 in boys is usually considered 
precocious (Lee, 1996). A “true” precocious puberty is due to central causes, whereas 
“pseudo” precocious puberty is due to peripheral causes. The central form can begin 
anytime after birth, is LHRH-dependent and characterized by hormonal changes similar 
to those that occur at the normal time of puberty. Such changes are increased pulsatile 
LH secretion, increased LH response to LHRH, and increased gonadal steroid secretion. 
Thus, in central precocious puberty there is a premature activation of the LHRH pulse 
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generator. In boys, this activation is usually accounted for by hypothalamic hamartomas, 
other central nervous system lesions, or familial disease with less than 10% being 
idiopathic. In girls, however, over 65% of the cases are considered idiopathic. There 
must be some underlying causes and any substance that can act centrally to stimulate 
LHRH release could possibly be involved. The present study indicates that Mn may be a 
candidate for such an action and that an early elevation of Mn, especially in females, 
could pose a risk for precocious sexual development. This may not necessarily mean 
high levels, but that if Mn accumulates in specific brain regions too early in life and 
reaches levels not normally attained until later, then a potential problem could arise. Our 
results support this possibility since we noted increased Mn accumulation in both the 
POA and, as others have shown, in the hypothalamus (Deskin et al, 1980) which is 
directly responsible for synthesis and secretion of LHRH. 
Mn enters the brain either through the cerebral vasculature or via the cerebral 
spinal fluid (CSF). The mechanism of crossing the blood brain barrier is not completely 
understood, but likely involves a function of Mn binding to transport systems such as 
transferrin (Aschner and Aschner, 1990; Aschner, 2000). As blood levels rise, influx into 
the CSF rises and entry across the choroid plexus becomes more important (Murphy et 
al., 1991). The POA and hypothalamus are adjacent to the third ventricle and receive Mn 
from both capillaries and the CSF. Importantly, Mn has been shown to cross the blood 
brain barrier over four times more efficiently in young animals compared with adults 
(Mena, 1974), and gender differences in Mn metabolism have been observed with male 
rats clearing Mn two times faster than female rats (Zheng et al., 2000).  
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Other facts also suggest we consider the possibility that elevated Mn levels may 
affect the timing of puberty. Some regions have high levels of Mn in the drinking water, 
and there is concern for high levels in some baby formulas (Lonnerdal et al., 1987). 
Also, there are now increased amounts in the air from addition of 
methylcyclopentadienyl Mn tricarbonyl (MMT) to gasoline (EPA, 2001), and certain 
foods are high in Mn and this could relate to consumption habits of families and certain 
cultures. This could become an even greater concern in areas where diets are iron 
deficient. Mn and Fe are both able to use a transferrin-dependent transport system 
(Malecki and Devenyi, 1999), thus Fe deficiency has been shown to potentiate the 
absorption and accumulation of Mn. 
It may be that any one of these excesses could be harmful, or it could take a 
combination of low level insults. Infants and children have been classified as being 
potentially more sensitive to excess Mn exposure (EPA, 2002) because the optimum 
level of exposure is not well defined (Greger, 1999), some evidence in animals that the 
young do not yet have full capacity to eliminate Mn (Fechter, 1999), and because tissue 
accumulation and health effects in humans, especially children, are not well understood.   
Our results demonstrate that Mn acts centrally to stimulate prepubertal 
LHRH/LH release, and can modestly advance the onset of puberty. The current 
understanding of the initiation of puberty is that the pituitary and gonad are capable of 
function at any age after a short period of priming (Lee, 1996). LHRH secretion is 
minimal during juvenile and childhood development and thus, this system is down-
regulated; however, as stated above when the secretion pattern of the peptide is 
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enhanced, the onset of puberty begins. The present results clearly show that Mn can act 
centrally to elicit the release of LHRH at this critical time of development. Whether this 
is a direct action on the LHRH neuronal system or an indirect action to activate or 
facilitate a known modulator of LHRH release will require further investigation.  
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CHAPTER III 
MANGANESE ACTS CENTRALLY TO ACTIVATE REPRODUCTIVE 
HORMONE SECRETION AND PUBERTAL DEVELOPMENT IN MALE RATS 
 
INTRODUCTION 
Manganese (Mn) is an abundant, naturally occurring element that is found as a 
component of over 100 minerals. This metal is considered an essential nutrient that is 
necessary for many normal mammalian physiological events, including those related to 
normal growth and development of bone and cartilage (Hurley, 1981), as well as 
connective tissue and the reproductive system (Greger, 1999; Keen et al., 1999). Mn is 
abundant in the environment, found in water, food, soil and air, and its absorption is 
affected by the age of an individual, route of exposure, the chemical form, as well as 
other dietary factors (ATSDR, 2000). Additionally, Mn is being used as an antiknock 
agent in gasoline (Thibault et al., 2002) which also contributes to environmental sources 
of exposure.  
Exposure to high levels of Mn is toxic, causing developmental and reproductive 
dysfunction (Gray and Laskey, 1980; Laskey et al., 1982). Interestingly, a Mn deficiency 
leads to impaired growth and reproduction in both sexes (Boyer et al., 1942; Smith et al., 
1944), demonstrating that it must play an important role in mammalian reproduction. We 
recently questioned whether Mn could be a factor contributing to hypothalamic events 
leading to sexual maturation. In this regard, we determined that exposure to low, but 
moderately elevated levels of the metal acted within the hypothalamus to cause 
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increased serum levels of puberty-related hormones and modestly, yet significantly, 
advanced the time of female puberty (Pine et al., 2005). This is potentially important 
since it suggests that if Mn levels rise and accumulate in the hypothalamus too early in 
life, the seemingly beneficial effect to facilitate puberty may actually be harmful by 
causing or contributing to precocious pubertal development. In support of this, infants 
and children have been suspected as being more sensitive to elevations in Mn (ATSDR, 
2000).  
At this time, no studies have been conducted to determine whether Mn can 
influence the neuroendocrine control of puberty in males. Thus, the present study was 
conducted to assess the ability of Mn to stimulate LH secretion in prepubertal male rats 
and to discern whether the site of this action is at the hypothalamic or pituitary level. 
Furthermore, we assessed whether short-term, low dose exposure to the metal during 
juvenile development would accelerate peripubertal spermatogenesis, a reliable indicator 
of male pubertal maturation. 
 
MATERIALS AND METHODS 
Immature male Sprague-Dawley rats, raised in our colony at the Texas A&M 
University Department of Comparative Medicine were housed under controlled 
conditions of light (lights on, 0600hr, lights off, 1800hr) and temperature (23 ºC), with 
ad libitum access to food and water. Harlan Teklad 2016 diet was provided, and 
contained 94.7 mg/kg Mn and 149.8 mg/kg iron, as assessed by the Heavy Metal 
Analysis Laboratory, Department of Veterinary Integrative Biosciences, College of 
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Veterinary Medicine, Texas A&M University. All procedures used were approved by the 
University Animal care and Use Committee and in accordance with the NIH Guidelines 
for the Care and Use of Laboratory Animals. 
Effect of centrally administered MnCl2 on LH secretion 
Thirty-five-day-old male rats were anesthetized with 2.5% tribromoethanol 
(Aldrich, Milwaukee, WI) and stereotaxically implanted with a stainless steel cannula 
(23 gauge) in the third ventricle of the brain and allowed five days for recovery 
(Antunes-Rodrigues et al., 1970). When the rats were 40 days old, a silastic cannula 
(Dow Corning, Midland, MI) was inserted into the right external jugular vein of each rat 
(Harms, 1974). The next day at 0900 hours, an extension of tubing was attached to each 
cannula and flushed with heparinized saline (100 IU/ml). After the animals were 
acclimated for an hour, three basal blood samples (250 µl) were drawn from each animal 
at 15-minute intervals. After the third basal sample, manganese chloride (MnCl2; Sigma 
Chemical Company, St. Louis, MO) at concentrations of 1, 2.5, 10, or 25 μg/3 μl, or an 
equal volume of saline was injected into the third ventricular cannula. Following the 
respective injection, four more samples were taken at 15 minute intervals for a total of 
seven samples. After blood sampling, brains were examined for proper cannula 
placement. Blood samples were centrifuged at 4°C, and serum was stored at -80°C until 
assayed for LH. 
Effect of MnCl2 on LHRH released from hypothalami in vitro 
Forty-day-old male rats were decapitated at 0900 hours, the medial basal 
hypothalamus (MBH) dissected under a stereomicroscope, rinsed, and incubated as we 
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have described previously (Pine et al., 2005). Briefly, the MBHs were placed in vials 
(one per vial) containing 0.35 ml incubation medium consisting of Locke’s buffer (2 
mM Hepes, 154 mM NaCl, 5.6 mM KCl, 1 mM MgCl2, 6 mM NaHCO3, 10 mM 
glucose, 1.25 mM CaCl2, and 1 mg/ml BSA, pH 7.4). Tissues were preincubated inside a 
Dubnoff shaker at 37˚C with constant shaking in an atmosphere of 95% O2 and 5% CO2 
for 15 minutes. The first incubation was discarded, and all MBHs were then incubated 
again in medium only for 30 minutes to establish basal LHRH release. After this 
incubation, the medium was collected, and replaced with medium only or medium 
containing 50, 250 or 500 µM MnCl2. After the second 30-minute incubation, the media 
were collected, boiled for 10 minutes to break down proteases, and then stored at -80˚C 
until assayed for LHRH. The MBHs were weighed to the nearest 0.01mg. 
Effect of LHRH receptor antagonism on Mn-induced LH release 
Third ventricular and external jugular cannulae were implanted as described 
above. The next day at 0900 hours, an extension of tubing was attached to each cannula 
and flushed with heparinized saline (100 IU/ml). Half of the animals received a single 
subcutaneous injection of acyline at a dose of 10 µg/0.1ml (Pine et al., 2005), a potent 
LHRH receptor antagonist (kindly provided by Dr. H.K. Kim, Contraception and 
Reproductive Health Branch, Center for Population Research, National Institute of Child 
Health and Human Development, Bethesda, MD). The other half of the animals was 
injected with an equal volume of saline. Acyline was allowed a two hour absorption 
period and then three basal blood samples were drawn from each freely moving animal 
at 15-minute intervals. Immediately following the third basal sample, a 3V injection of 
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MnCl2 (10 µg/3µl) was administered to all of the animals. Four more blood samples 
were taken at 15-minute intervals for a total of seven samples. After the experiment, 
brains were examined for proper cannula placement. Blood samples were centrifuged at 
4°C and serum was stored at –80 °C until assayed for LH. 
Effect of chronic oral Mn exposure on puberty-related hormones, steroidogenesis 
and spermatogenesis 
Mature females were bred and delivered their pups normally. Litters were 
adjusted to 8-11 pups with at least 6 males per litter. At 15 days of age, the males from 
each litter were divided into 3 groups. Groups 1 and 2 received 10 and 25 mg/kg MnCl2, 
respectively. Administration was such that 0.258 mg or 0.625 mg MnCl2 was delivered 
in 0.2 ml/25 g rat daily by a gastric gavage injection. Group 3 served as controls and 
received an equal volume of saline. The rats were killed by decapitation between 0900-
1000 hours on day 48 or day 55. Trunk blood was collected and allowed to clot, then the 
serum stored frozen at -80ºC until used for RIA assessment of puberty-related hormones. 
At this time the testes were also collected and processed for analysis of spermatogenic 
development as described below.   
 Sperm production was measured by methods we have described previously 
(Johnson et al., 1980). Briefly, thawed testes were separated from epididymides before 
the testes were weighed. Both testes were decapsulated, the tunica albuginea weighed, 
and the testis homogenized for two minutes in 100 ml of homogenizing fluid containing 
150 mM NaCl, 0.05% (v/v) Triton X-10, and 3.8 mM NaN3 (Johnson et al., 1980). 
Testicular homogenates were stored at 5 °C and evaluated within 28h. Only spermatid 
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heads with a shape characteristic of steps 17 through 19 found in stages IV and VIII 
(Leblond et al., 1952) are resistant to such homogenization; these were enumerated by 
phase-contrast cytometry. Duplicate evaluations were made by each of two evaluators 
for the right and left side of each rat (Johnson et al., 1984). Daily sperm production per 
testis (DSP/testis) is a measure of total daily sperm production by each testis, and was 
calculated by dividing the number of homogenization-resistant spermatids by the life 
span of these spermatids (6.3 days) (Johnson et al., 1980; Amann et al., 1976). Daily 
sperm production per gram testicular parenchyma (DSP/g), a measure of efficiency of 
spermatogenesis, was calculated by dividing the DSP/testis by the difference between 
testis and tunic weights. Both methods are reliable indicators of spermatogenic 
development (Amann et al., 1976). 
Hormone analysis 
Rat serum LH and FSH were measured using radioimmunoassay (RIA) 
procedures we have described previously (Hiney et al., 1996). Rat LH antiserum 
(NIDDK-anti-rLH-S-II), antigen (NIDDK-rLH-I-9), and reference preparation (NIDDK-
rLH-RP-3); and rat FSH antiserum (NIDDK-rFSH-I-9), and reference preparation 
(NIDDK-rFSH-RP-2) were purchased from the NIH Pituitary Hormones & Antisera 
Center, Harbor-UCLA Medical Center, Torrance, California. The LH assay had a 
sensitivity of 0.07 ng/ ml and the FSH assay had a sensitivity of 0.4 ng/ml. The LHRH 
was measured as previously described (Hartter et al., 1985) using antisera N0.R11B73 
kindly provided by Dr. V.D. Ramirez. Synthetic LHRH used for the standards and 
iodinations was purchased from Sigma Chemical Co. (St. Louis, MO). The sensitivity of 
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the LHRH assay was 0.2 pg/tube. The serum levels of testosterone were measured by an 
RIA kit purchased from Diagnostic Products Corp. (Los Angeles, CA). The sensitivity of 
the testosterone assay was 0.1 pg/ml. All of the assays had inter- and intra-assay 
coefficients of variation of <10%. 
Statistical analysis 
All values are expressed as the mean (±SEM). Gaussian distribution was 
determined by the method of Kolmogorov-Smirnov. Differences between treatment 
groups were analyzed either by Student’s t test or by Kruskal-Wallis nonparametric 
analysis of variance (ANOVA) followed by post hoc testing using Dunn’s multiple 
comparisons test. P-values less than 0.05 were considered significant. The IBM PC 
programs INSTAT and PRISM (GraphPad, San Diego, California) were used to 
calculate and graph the results. 
 
RESULTS 
Effect of centrally administered MnCl2 on LH secretion 
Central administration of MnCl2 stimulated prepubertal LH release significantly 
and dose dependently over basal levels (Fig. 3.1). The rats that were injected with saline 
or the 1.0 µg dose of MnCl2 exhibited no change in LH released as compared to their 
respective basal levels. However, the rats that were injected with the 2.5, 10 and 25 µg 
doses of MnCl2 exhibited 3-, 6- and 7-fold increases in LH release, respectively, 
compared with their basal levels.  
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Figure 3.1. The effect of 3V administration of MnCl2 on LH release in immature male rats during 
late juvenile phase of development. 
Bars depict basal vs. stimulated serum levels of LH. The animals received either saline (0) or the 
designated dose of MnCl2. Animals which received the 2.5 µg dose of MnCl2 or higher showed a marked 
increase in LH secretion compared to basal levels. Values represent mean ± SEM. The number of animals 
is depicted within each panel (**, p< 0.01).  
 
 
 
Effect of MnCl2 on LHRH release from hypothalami in vitro 
Hypothalami from prepubertal male rats were incubated in vitro with three 
concentrations of MnCl2. The addition of MnCl2 to the medium caused a dose dependent 
stimulation in the release of LHRH compared to basal levels (Fig. 3.2). Specifically, 
MBHs incubated in Locke’s Buffer without MnCl2, or with the lowest dose of the metal 
(50 µM), showed no significant change in LHRH secreted between their respective basal 
and challenge incubation periods. However, marked increases in the amount of LHRH 
released were observed when the hypothalami were incubated with 250 µM (p < 0.01) 
and 500 µM (p < 0.01) concentrations of MnCl2.  
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Figure 3.2. The effect of MnCl2 on LHRH release from MBHs of immature male rats in vitro. 
Bars depict basal vs. stimulated levels of LHRH. MBHs were first incubated in Locke’s Buffer alone to 
assess basal LHRH release, then again with either Locke’s buffer alone (0) or with the buffer containing 
increasing concentrations of MnCl2 to determine the stimulated response. The presence of Mn caused a 
dose dependent increase in LHRH release. Values represent mean ± SEM. The number of tissue samples is 
depicted within each panel (**, p< 0.01). 
 
 
 
Effect of LHRH receptor antagonism on Mn-induced LH release 
To further support that the Mn acted at the level of the hypothalamus and not the 
pituitary, rats were treated with the LHRH receptor antagonist, acyline, prior to the 
central administration of MnCl2. Figure 3.3 illustrates that MnCl2 injected directly into 
the third ventricle markedly (p < 0.01) stimulated LH release over basal levels in control 
animals but not in the animals that were pre-treated with acyline.  
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Figure 3.3. The effect of pretreatment with the LHRH receptor antagonist, Acyline, on MnCl2-
stimulated LH release in immature male rats.  
Control animals (no acyline) exhibited a marked Mn-induced increase in serum levels of LH compared to 
their basal levels. Conversely, the acyline-treated animals did not respond to the Mn stimulation. Values 
represent mean ± SEM. The number of animals is depicted within each panel (**, p< 0.01). 
 
 
 
Effect of chronic oral Mn exposure on puberty related hormones, steroidogenesis 
and spermatogenesis    
Compared to control animals, serum gonadotropin levels were not altered at 48 
or 55 days in animals that received the 10 mg/kg supplemental dose of MnCl2 (not 
shown). The 25 mg/kg dose caused non-significant elevations in LH, FSH, testosterone 
and spermatogenesis by 48 days (not shown). However, supplementation of animals with 
the 25 mg/kg dose of Mn until 55 days of age produced increased levels of mean serum 
LH (Control: 0.99 ± 0.06 ng/ml vs. Mn: 1.85 ± 0.36 ng/ml; P<0.02) and FSH (Control: 
29.7 ± 1.5 ng/ml vs. Mn: 36.9 ± 1.5 ng/ml; P<0.01) and testosterone (Control: 2 ± 0.19 
ng/ml vs. Mn: 2.85 ± 0.3 ng/ml; P<0.05) compared with the control animals (fig. 3.4 a, b 
& c). Furthermore, compared with levels in controls, daily sperm production per testis 
(DSP/testis) and daily sperm production per gram of testicular parenchyma (DSP/g), 
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which are key indicators of male pubertal development, were both increased (p <0.05) 
by 55 days of age in the animals supplemented with the 25 mg/kg dose of MnCl2 (Fig. 
3.5 a & b).  
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Figure 3.4. Effect of chronic oral administration of MnCl2 on serum LH, FSH and testosterone in 55 
day old male rats. 
Serum LH, FSH and testosterone levels from control animals and animals which received the 25 mg/kg 
dose of MnCl2 from day 15 through day 55 of life are depicted (panels A-C, respectively). Values 
represent the mean ± SEM. The number of animals represented in each panel is depicted within panel A 
(+, p <0.02; *, p < 0.05; **, p < 0.01 respectively vs. control). 
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Figure 3.5. Effect of chronic oral administration of MnCl2 on spermatogenesis of immature male 
rats.   
Male rats received either MnCl2 or saline by gastric gavage from day 15 through day 55 of life. These data 
depict the effect of MnCl2 (25mg/kg) supplementation on daily sperm production per testis (panel A) and 
efficiency of sperm production as assessed by daily sperm production per gram parenchyma (panel B). 
Values represent mean ± SEM. The number of animals is depicted within each bar (*, p< 0.05). 
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DISCUSSION 
 The present study demonstrates an action of Mn to stimulate prepubertal LHRH 
and gonadotropin secretion, and to significantly elevate the rate of daily mature sperm 
production, an indicator of pubertal development in males. Our results depict three lines 
of evidence demonstrating that the hypothalamus is the site of the Mn action on LH 
secretion in prepubertal male rats: 1) the third ventricular administration of MnCl2 
stimulated a dose dependent release in LH, 2) the metal stimulated LHRH release 
directly from the MBH in vitro, and 3) the LHRH receptor antagonist, acyline, 
effectively blocked LHRH receptors on the pituitary, thus inhibiting the Mn-induced 
release of LH following third ventricular administration. Collectively, these data indicate 
that Mn acts within the hypothalamus to facilitate the secretion of LH, a key hormone 
controlling Leydig cell production of testosterone, which subsequently, drives the 
increase in spermatogenesis during pubertal development.  
 The age at which the normal onset of puberty begins is variable and depends on 
a complex series of events within the hypothalamus that culminate in the increased 
secretion of LHRH. The current understanding of the initiation of puberty is that the 
pituitary and gonad are capable of function at any age after a short period of exposure to 
LHRH (Lee, 1996). LHRH secretion is minimal during juvenile and childhood 
development and thus, this system is down-regulated; however, when the secretion 
pattern of the peptide is enhanced, the onset of puberty begins. The ability of low doses 
of Mn to act centrally to elicit prepubertal LHRH/ LH secretion is important and 
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suggests a facilitative role of the metal at the time of puberty by subsequently enhancing 
testosterone production and spermatogenic development. 
 Chronic administration of high levels of Mn is known to cause toxic effects to 
adult male reproduction by decreasing sperm count and motility, thus, resulting in 
decreased fertility (Ponnapakkam et al., 2003; Elbetieha et al., 2001). The effects of low, 
yet slightly elevated levels of the metal during prepubertal development have not been 
investigated. The present study is the first to show that chronic low level MnCl2 
supplementation to immature male rats caused significant increases in the prepubertal 
levels of serum LH, FSH and testosterone, and that these elevations were associated with 
increased spermatogenesis compared to controls. 
 Regarding spermatogenesis, daily sperm production and efficiency, both key 
indicators of spermatogenesis used in the present study, showed significant increases in 
the Mn-treated rats. The values obtained from our control animals were similar to those 
reported previously for rats at this age (Robb et al., 1978), but were less than those 
attained in adult rats (Johnson et al., 1980; Robb et al., 1978; Johnson et al., 1984). The 
fact that the 25 mg/kg dose of Mn enhanced the efficiency of spermatogenesis to a 
DSP/g of 18 million is important. This increased efficiency, coupled with no change in 
testicular weight, yielded significantly enhanced daily sperm production per testis in the 
Mn-treated animals, results which were positively associated with puberty-related 
hormones. It is well known that LH acts on spermatogenesis via stimulating production 
of testosterone, and there is existing evidence that both FSH and testosterone are capable 
of stimulating all phases of spermatogenesis (Simoni et al., 1999). These authors 
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presented evidence that a combination of FSH and testosterone supported 
spermatogenesis both qualitatively and quantitatively in a man hypophysectomized for a 
pituitary tumor. These observations are consistent with the results of our study showing 
that exposure to low levels of Mn increased puberty-related homones, and enhanced 
spermatogenesis. Thus, our results suggest that the Mn-treated rats were maturing at an 
accelerated rate compared to the age matched control animals. 
 We have previously demonstrated similar effects in females (Pine et al., 2005); 
however, by comparing results from the two studies we can now suggest a gender 
difference in responsiveness to this metal. In females, a 10 mg/kg dose of Mn was 
effective in significantly elevating serum gonadotropins and advancing the time of 
vaginal opening. In males, a 25 mg/kg dose of Mn was required to significantly elevate 
serum gonadotropins and accelerate spermatogenesis; hence, suggesting that the males 
are less sensitive to the hypothalamic influence of Mn than females. Even though a 
greater oral dose of Mn was required for males, it is important to note that it was still 
much lower than doses shown to produce neurotoxicological effects in adult rats and 
primates (Newland, 1999). One explanation for the males requiring a higher level of Mn 
exposure could be metabolic variations due to gender differences in Mn metabolism. In 
this regard, male rats have been shown to clear Mn two times faster than female rats 
(Zheng et al., 2000).  
The onset of puberty in boys before the age of 9.5 years is usually considered 
precocious (Lee, 1996). True precocious puberty is due to a premature activation of the 
LHRH pulse generator, and approximately 10% of these cases are idiopathic. Some 
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underlying cause is inevitable and any substance that can act centrally to induce LHRH 
release could be involved. Results presented here suggest the potential for slightly 
elevated levels of Mn to contribute to such an effect. Importantly, we demonstrated 
conclusively that the site of action of Mn is within the hypothalamus, a brain region in 
close proximity to the third ventricle. Mn is able to enter the brain either through the 
cerebral vasculature or via the cerebral spinal fluid, and has been shown to accumulate in 
the hypothalamus of young animals (Pine et al., 2005; Deskin et al., 1980). The 
mechanism of crossing the blood brain barrier is not completely understood, but likely 
involves a function of Mn binding to transport systems such as transferrin (Aschner and 
Aschner, 1990; Aschner, 2000). Mn has been shown to cross the blood brain barrier over 
four times more efficiently in young animals, which do not have full capacity to 
eliminate this metal (Mena, 1974). Although the minimum level of exposure is not well 
defined (Greger, 1999), infants and children have been classified as being potentially 
more sensitive to excess Mn (USEPA, 2002). These observations further support the 
potential for Mn to influence the timing of male puberty.  
The fact that Mn has the potential to facilitate pubertal development places it in a 
unique category of a limited number of substances capable of advancing the timing of 
puberty. Other substances include Insulin like growth factor-1 (Hiney et al., 1996), 
leptin (Chehab et al., 1997), kisspeptin (Navarro et al., 2004), and excitatory amino 
acids that can activate the N-methyl-D-aspartic acid receptor (Gay and Plant, 1987). 
Because Mn is a natural element, our results suggest it may be an environmental factor, 
which may work in concert with the above metabolic signals as well as genetic factors to 
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influence pubertal development. At the present time the mechanism of Mn action to 
stimulate LHRH release has not been entirely discussed, but we have recent evidence 
that the stimulatory effects are mediated by the cGMP/protein kinase G pathway (Lee et 
al., 2006).   
In conclusion, the present data clearly show that exposure to low levels of Mn 
during juvenile development can induce the prepubertal release of LHRH, causing 
elevated circulating levels of LH, FSH and testosterone; hence, resulting in increased 
spermatogenesis commensurate with accelerated pubertal development compared to age 
matched controls. These results suggest that Mn may play a role at the time of normal 
pubertal development, but also indicate a possible increased risk for precocious pubertal 
development if males are exposed to moderately elevated levels of Mn too early in life.  
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CHAPTER IV 
MANGANESE INDUCES HYPOTHALAMIC LUTEINIZING HORMONE 
RELEASING HORMONE SECRETION BY ACTIVATING GUANYLYL 
CYCLASE IN THE FEMALE RAT 
 
INTRODUCTION 
 Manganese (Mn) is an abundant, naturally occurring essential element that is 
required for normal mammalian physiological events, including those related to normal 
growth and development of bone and cartilage (Hurley, 1981), as well as connective 
tissue and the reproductive system (Greger, 1999; Keen et al., 1999). It has been known 
for many years that Mn deficiencies in laboratory animals are associated with impaired 
growth and reproduction in both sexes (Boyer et al., 1942; Smith et al., 1944); thus, 
suggesting a role in the reproductive process. Because Mn crosses the blood brain barrier 
over four times more efficiently in young versus adult animals (Deskin et al., 1980), and 
because it can accumulate in the hypothalamus (Deskin, et al., 1980; Pine, et al., 2005), 
we hypothesized that it may influence the neuroendocrine system just prior to puberty. 
Therefore, we have recently conducted studies to assess specifically, whether Mn 
contributes to the secretion of puberty-related hormones and the timing of puberty. In 
this regard, we used both in vitro and in vivo studies to demonstrate that Mn can 
stimulate the secretion of luteinizing hormone releasing hormone (LHRH) and 
luteinizing hormone (LH), respectively, in immature female rats (Pine et al., 2005). In 
that same study, we also assessed the effects of supplementing the diet of immature 
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female rats with a low dose of Mn from day 12 until day 29, or, in some animals until 
vaginal opening (VO). This diet regimen resulted in a significant elevation in the serum 
levels of LH, follicle stimulating hormone (FSH) and estradiol (E2), and a moderate but 
significant advancement in the age at VO. More recently, we have observed similar 
elevations in puberty-related hormones in immature males, as well as increases in both 
daily sperm production and efficiency of spermatogenesis in age matched male controls. 
While this indicates that Mn can accelerate maturation in males (Lee et al., 2006), it is 
important to note that the Mn dose required for this was 2.5 fold greater than that which 
we showed to accelerate female puberty (Pine et al., 2005); hence, suggesting that the 
female is more sensitive in this regard. Taken together, the above studies indicate clearly 
that Mn is capable of acting within the hypothalamus to influence LHRH release during 
prepubertal development. 
 At the present time the hypothalamic mechanism by which Mn acts to facilitate 
prepubertal LHRH secretion is not known. Because nitric oxide (NO) is stimulatory on 
LHRH release (Rettori et al., 1993), and because of the ability of NO to activate soluble 
guanylyl cyclase (sGC) and the fact that the Mn cation is the preferred cofactor for 
activation of this enzyme (Murad, 1994), we questioned whether this pathway was the 
site of action for Mn-induced LHRH secretion. Since it is not known whether the Mn 
can effectively stimulate hypothalamic NO directly, or whether the principal action may 
reside in regulating activation of sGC, we investigated whether Mn stimulation of LHRH 
secretion involves an action within the NO/ guanylyl cyclase (GC)/ cyclic GMP 
(cGMP)/ protein kinase G (PKG) signaling pathway.  
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MATERIALS AND METHODS 
Immature female rats of the Sprague-Dawley line raised in our colony at the 
Texas A&M University Department of Comparative Medicine were used for these 
experiments. The animals were housed under controlled conditions of photoperiod 
(lights on, 0600 hr, lights off, 1800 hr) and temperature (23 ºC), with ad libitum access 
to food and water. The diet was Harlan Teklad 2016 which contained 94.7 mg/kg Mn 
and 149.8 mg/kg iron (Fe) as analyzed by the Heavy Metal Analysis Laboratory, 
Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, 
Texas A&M University. All procedures used were approved by the University Animal 
Care and Use Committee and in accordance with the NIH Guidelines for the Care and 
Use of Laboratory Animals. 
In vivo Experiments 
Inhibition of N-methyl-DL- aspartic acid receptors (NMDA-R) 
Twenty-three-day-old female rats were anesthetized with 2.5% tribromoethanol 
(Aldrich, Milwaukee, WI ) and stereotaxically implanted with a stainless steel cannula 
(23 gauge) in the third ventricle (3V) of the brain and allowed five days for recovery 
(Antunes-Rodrigues and McCann, 1970). When the rats were 29 days old, they were 
anesthetized with 2.5% tribromoethanol and silastic cannulae were inserted into the right 
external jugular vein of each rat (Harms and Ojeda, 1974). The next day, an extension of 
tubing was attached to each cannula and flushed with heparinized saline (100 
IU/ml). Following a one hour acclimation period, two basal blood samples (250 µl) were 
drawn from each freely moving animal at 15-minute intervals. Half of the animals were 
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given an intravenous injection of a specific antagonist of NMDA-R, MK801 (0.15 
mg/kg; Macdonald and Wilkinson, 1990; Brann and Mahesh, 1991), and the other half 
were given saline. Two additional samples were taken at 15 minute intervals and then a 
third ventricular injection of 10 µg/3 µl of manganese chloride (MnCl2; Sigma Chemical 
Company, St. Louis, MO) was administered into the 3V. Following this injection, four 
additional samples were taken for a total of eight samples. This dose of MnCl2 was 
determined in a previous study (Pine et al., 2005). After the experiment, animals were 
euthanized with an overdose of tribromoethanol, and brains were examined for proper 
cannula placement. Animals were confirmed to be in the juvenile phase of development 
by criteria we have previously used (Dees and Skelley, 1990). Blood samples were 
centrifuged at 4 °C, and serum was stored at –80 °C until assayed for LH. 
Inhibition of insulin-like growth factor-1 receptors (IGF1-R)  
Twenty-three-day-old female rats were treated in the same manner as described 
above except for the following modifications. After the two basal blood samples were 
taken, a IGF1-R inhibitor, JB1 (8 mg; Quesada and Etgen, 2002) or an equal volume of 
saline was administered into the 3V, then two blood samples were taken at 15 minute 
intervals. MnCl2 was then administered into the 3V and three additional samples were 
taken for a total of seven samples. Euthanasia of animals, confirmation of cannula 
placement and stage of cycle, as well as blood sample storage were as described above. 
Inhibition of nitric oxide synthase (NOS) 
Twenty-three-day-old female rats were treated as above except for the following 
modifications. After the two basal blood samples were taken, the NOS inhibitor, N-
 47
monomethyl-L-arginine (NMMA) (1 mg; Rettori et al., 1993) or an equal volume of 
saline was administered into the 3V. After 60 minutes, a third blood sample was taken 
and then a second dose of NMMA or saline was administered as above. Fifteen minutes 
later, a fourth blood sample was taken then MnCl2 (10 µg/3µl) was administered into the 
3V and three additional samples were taken for a total of seven samples. Euthanasia of 
animals, confirmation of cannula placement and stage of cycle, as well as blood sample 
storage were as described above. 
In vitro Experiments 
Thirty day-old female rats were decapitated, and the brain removed. The medial 
basal hypothalamus (MBH) was dissected by vertical cuts along the posterior side of the 
optic chiasm and the anterior edge of the mammillary bodies and laterally at the 
tuberoinfundibular sulci of the hypothalamus. The tissue was incubated as described 
previously (Nyberg et al., 1993) with minor modifications. Briefly, each MBH was 
incubated in a vial containing 350 µl of Locke’s Buffer (2mM Hepes, 154 mM NaCl, 5.6 
mM KCl, 1 mM MgCl2, 6 mM NaHCO3, 10 mM glucose, 1.25 mM CaCl2, and 1 mg ml-
1 BSA, pH 7.4) inside a Dubnoff shaker (80 cycles/min) at 37 ºC in an atmosphere of 
95% O2 and 5% CO2. After a 30 min equilibration period, the initial incubation medium 
was discarded, and all MBH’s were incubated in fresh medium for 30 minutes to 
establish basal LHRH release. The medium was replaced with medium only or medium 
plus NMMA (300 or 500 µM; Karanth et al., 2004), 1H-[1,2,4], oxadiazolo [4,3-a] 
quinoxalin-1-one (ODQ) (100 or 250 µM; Karanth et al., 2004), or KT5823 (10 µM), for 
30 minutes then removed and stored in microcentrifuge tubes. The medium was then 
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replaced with medium containing 50 or 250 µM MnCl2 (Pine et al., 2005) or medium 
with MnCl 2 plus NMMA, ODQ, or KT5823. The MBHs were incubated for an 
additional 30 minutes before these medium samples were collected. All of the samples 
were boiled for 10 minutes, and then stored at – 80 ºC until assayed for LHRH. MBHs 
were weighed to the nearest 0.1 mg. 
  In two other experiments, the medium was removed after equilibration and 
replaced with fresh medium for a 30 min incubation in order to establish basal secretion 
of total nitrite (NO2- ) and LHRH, or cGMP and LHRH. In each case the medium was 
saved, then replaced with medium containing 50 or 250 µM MnCl2 and the tissues 
incubated for a final 30 minutes. The medium samples were collected, aliquoted, boiled 
for 10 minutes and then stored frozen until assayed for NO2- and LHRH, or cGMP and 
LHRH, respectively. As above, the tissues were weighed to the nearest 0.1 mg. 
 Hormone analysis 
 Rat LH was measured using radioimmunoassay (RIA) procedures as previously 
described (Hiney et al., 1996). The rat LH antiserum (NIDDK-anti-rLH-S-II), antigen 
(NIDDK-rLH-I-9), and reference preparation (NIDDK-rLH-RP-3) were purchased from 
the NIH Pituitary Hormones & Antisera Center, Harbor-UCLA Medical Center, 
Torrance, CA. The LH assay had a sensitivity of 0.07 ng/ ml, and the inter- and intra-
assay coefficients of variation was < 10%. The LHRH was measured as previously 
described (Nyberg et al., 1993) using Antisera N0.R11B73 kindly provided by Dr. V.D. 
Ramirez. Synthetic LHRH used for the standards and iodinations was purchased from 
Sigma Chemical Co. (St. Louis, MO). The sensitivity of the assay was 0.2 pg/ tube, and 
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the intraassay coefficient of variation was < 10%. Total NO2- and cGMP were measured 
by kits purchased from Caymen Chemical, Ann Arbor, MI. The sensitivity of the NO2- 
and nonacetylated cGMP assays were 1 μM and 0.1 pmol ml-1, respectively.  
Statistical analysis 
All values are expressed as the mean (± SEM). Differences between treatment 
groups were analyzed by Kruskal-Wallis nonparametric analysis of variance (ANOVA) 
followed by post hoc testing using Student-Neuman-Keuls multiple range test and where 
appropriate, the Student t test. P-values less than 0.05 were considered significant. The 
IBM PC programs INSTAT and PRISM (GraphPad, San Diego, CA) were used to 
calculate and graph the result. 
 
RESULTS 
Effects of NMDA-R inhibition on MnCl2-induced LH release 
Figure 4.1 shows that the intravenous administration of saline or MK801 alone 
did not alter basal LH levels. The central administration of MnCl2 (10 µg/ 3 µl) 
stimulated LH release in both control (panel A; **p<0.01) and compared with basal 
levels in animals that received either saline or MK801-treated (panel B; ***p<0001) 
animals.  
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Figure 4.1. Effect of MK801 on Mn-induced LH release in vivo.  
Open bars represent basal LH release. Grey bar represents LH release after MK801. Hatched bars 
represent LH release following central administration of MnCl2 (10 ug/3ul) in the absence (panel A) or 
presence (panel B) of the inhibitor. Note that Mn stimulated LH release (panel A) and this action was not 
inhibited by the presence of the NMDA-R inhibitor (panel B). **p< 0.01 vs basals. ***p< 0.001 vs basal 
and MK801. Each bar represents the mean (±SEM). N= 5 for panels A and B respectively.  
 
 
 
Effect of the IGF1-R inhibition on MnCl2-induced LH release 
Figure 4.2 shows that basal LH release was not altered by a 3V injection of either 
saline or JB1. The central administration of MnCl2 (10 µg/ 3 µl) stimulated (**p<0.01) 
LH release in both groups similarly compared to their basal levels.  
 51
basal basal Mn basal JB1 Mn
0.0
2.5
5.0
7.5
**
**
A B
LH
(n
g/
m
l)
 
Figure 4.2. Effect of JB1 on Mn induced-LH release in vivo.  
Open bars represent basal LH release. Grey bar represents LH release after JB1. Hatched bars represent 
LH release following central administration of MnCl2 (10 ug/3ul) in the absence (panel A) or presence 
(panel B) of the inhibitor. Note that Mn stimulated LH release (panel A) and this action was not inhibited 
by the presence of the IGF1-R inhibitor (panel B). **p< 0.01 vs basals and JB1. Each bar represents the 
mean (±SEM). N= 13 for panels A and B respectively. 
 
 
 
Effect of NOS inhibition on MnCl2-induced LH release 
 Figure 4.3 shows that the central administration of saline or NMMA (1 mg), did 
not alter basal LH levels. The central administration of MnCl2 (10 µg/ 3 µl) stimulated 
LH release in both control (panel A; ***p<0.001) or NMMA-treated (panel B; *p<0.05) 
animals compared with basal levels.  
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Figure 4.3. Effect of NMMA on Mn-induced LH release in vivo.  
Open bars represent basal LH release. Grey bar represents LH release after NMMA. Hatched bars 
represent LH release following central administration of MnCl2 (10 ug/3ul) in the absence (panel A) or 
presence (panel B) of the inhibitor. Note that Mn stimulated LH release (panel A) and this action was not 
inhibited by the presence of the NOS inhibitor (panel B). *** p< 0.01 vs basals. * p<0.05 vs basal and 
NMMA. Each bar represents the mean (±SEM). N= 9 and 8 for panels A and B respectively.  
 
 
 
Effect of NOS inhibition on MnCl2-induced LHRH release 
 Figure 4.4 demonstrates that the basal release of LHRH from the MBH was not 
altered by medium alone (Fig 4.4 A and C) or the medium containing 300µM NMMA 
(Fig 4.4 B and D). The addition of 50µM MnCl2 to the medium caused an increase in the 
amount of LHRH released from both control tissues (Fig 4.4 A; p<0.05) and tissues 
exposed to 300µM NMMA (Fig 4.4 B; p<0.05). Furthermore, the addition of 250µM 
MnCl2 likewise caused increased LHRH release from control tissues (Fig 4.4.C; p<0.01), 
as well as in tissues exposed to both 300µM NMMA (Fig 4.4 D; p<0.05) and 500µM 
NMMA (p<0.05, not shown). 
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Figure 4.4. Effect of NOS inhibition using NMMA on MnCl2-induced LHRH release.  
Open bars represent basal LHRH release. Grey bar represents LHRH release in the presence of NMMA 
only. Black bars represent LHRH released following 50µM MnCl2 stimulation in the absence (panel A) or 
presence (panel B) of NMMA. Hatched bars represent LHRH released following 250µM MnCl2 
stimulation in the absence (panel C) or presence (panel D) of the inhibitor. Note that Mn stimulated LHRH 
release in control tissues after both doses (panels A and C), and that this action was not altered by the 
presence of the NOS blocker (panels B and D).  *p<0.05 vs medium only or medium plus NMMA; ** 
p<0.01 vs respective medium only. Each bar represents the mean (±SEM). N= 8, 9, 11 and 10 for panels 
A, B, C and D respectively.  
  
 
 
Effect of MnCl2 on NO2- release  
In order to assess more directly a potential effect of Mn on tissue NO formation, 
we measured the amount of total NO2-, an indicator of NO generation, and LHRH 
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release from the same tissue incubates.  The 50µM MnCl2 failed to induce NO2- 
released into the medium (Fig 4.5 A), but did stimulate a marked increase in LHRH 
released (Fig 4.5 B; p<0.001). Identical results were noted following a 100µM dose of 
MnCl2 (not shown). The 250µM dose of MnCl2 did, however, induce the release of both 
NO2- (Fig 4.5 C; p<0.001) and LHRH (Fig 4.5 D; p<0.001).  
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Figure 4.5. Effect of MnCl2 on NO2- (as an assessment of NO production) and LHRH release from 
the same tissues.  
Open bars represent basal NO2- and LHRH released into the medium. Black or hatched bars represent 
NO2- and LHRH released following MnCl2 stimulation at doses of 50µM and 250 µM, respectively. Note 
that the 50µM Mn dose did not stimulate NO2- (panel A), but markedly induced LHRH release (panel B). 
The 250µM Mn dose caused stimulations in both NO2- (panel C) and LHRH (panel D). Together, this 
suggests that Mn can only stimulate NO production at higher concentrations. Each bar represents the mean 
(±SEM). The number of tissues/group is depicted within each panel. ***p < 0.001 vs medium only. N=9 
for panels A and B; N=14 for panels C and D.  
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 Effect of GC inhibition on MnCl2-induced LHRH release 
 Figure 4.6.A-C shows that the basal secretion of LHRH was not affected by 
medium alone or medium containing doses of 100 and 250µM ODQ. The subsequent 
addition of MnCl2 to the medium elicited a marked increase (p<0.001) in LHRH 
released from control tissues (Fig 4.6 A), but this action was blunted markedly by the 
100µM dose of ODQ and blocked by the 250µM dose of the inhibitor (Figs 4.6 B and C, 
respectively). 
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Figure 4.6. Effect of GC inhibition using ODQ on Mn-induced LHRH release.  
Open bars represent basal LHRH release. Grey bars represent LHRH released in the presence of ODQ. 
Hatched bars represent LHRH released following 250µM MnCl2 stimulation in the absence (panel A) or 
presence (panels B and C) of the inhibitor. Note that the Mn stimulated LHRH release from control tissues 
(panel A), but this stimulatory effect was dose dependently blocked (panels B and C) by the presence of 
the sGC inhibitor in the medium. ***p<0.01 vs medium only. *p<0.05 vs medium only and medium plus 
ODQ. Each bar represents the mean (±SEM). N=20, 11 and 15 for panels A, B and C respectively.  
  
 
 
Effect of MnCl2 on cGMP release 
 Basal and MnCl2-stimulated release of both cGMP and LHRH were assessed 
from the same MBH tissue incubates. The 50µM dose of MnCl2 induced an increase (p 
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<0.05) in the amount cGMP released over basal levels (Fig 4.7 A), an effect that was 
accompanied by an increase (p<0.01) in the release of LHRH (Fig 4.7 B). Similar 
stimulations were observed for both cGMP and LHRH following addition of the 250µM 
dose of MnCl2 (not shown).  
 
 
 
Figure 4.7. Manganese stimulates cGMP and LHRH release.  
Open bar represents basal cGMP and LHRH release. Solid bars represent cGMP and LHRH released 
following addition of 50µM MnCl2 into the medium. Note that Mn stimulated both cGMP (panel A) and 
LHRH (panel B) secreted from the same tissue incubates. *p < 0.05 and **p < 0.01 versus basal levels. 
Each bar represents the mean (±SEM). N=8 for panels A and B, respectively.  
 
 
 
 Effect of PKG inhibition on MnCl2-induced LHRH release 
 Figure 4.8 A and B shows that basal secretion of LHRH was not affected by 
medium alone or medium containing KT5823. The addition of 250µM of MnCl2 to the 
medium elicited an increase (p<0.05) in LHRH released from control tissues, but failed 
to induce stimulation of the peptide in the tissues exposed to the inhibitor. 
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Figure 4.8. Effect of PKG inhibition using KT5823 on Mn-induced LHRH release.  
Open bars represent basal LHRH release. Grey bar represents LHRH released in the presence of 10 µM 
KT5823. Hatched bars represent LHRH released following 250 µM MnCl2 stimulation in the absence 
(panel A) or presence of (panel B) of the inhibitor. Note that Mn stimulated LHRH release in control 
tissues (panel A), but was unable to stimulate LHRH release when the PKG blocker was present in the 
medium. *p<0.05 vs medium only. Each bar represents the mean (±SEM). N=8 for panels A and B, 
respectively. 
 
 
 
DISCUSSION 
We showed previously that MnCl2 is capable of acting at the hypothalamic level 
to stimulate LHRH release in prepubertal animals. Specifically, in our initial study, we 
showed in prepubertal female rats that Mn, when administered into the third ventricle, 
caused a dose-dependent release in LH. Furthermore, prior exposure to acyline, an 
LHRH receptor antagonist, blocked the central action of Mn to stimulate LH, and that 
Mn dose-dependently stimulated LHRH release directly from medial basal hypothalami 
incubated in vitro (Pine et al., 2005). In that study, we also demonstrated that the serum 
levels of LH, FSH and E2 were elevated significantly, and that the day of vaginal 
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opening (VO) was advanced when the diet of developing female rats was supplemented 
with a low dose of Mn beginning when the rats were 12 days old.    
     The present results demonstrate the site and mechanism by which Mn induces 
prepubertal LHRH/ LH secretion in female rats. In this regard, we showed that blocking 
receptors such as NMDA-R or IGF1-R did not alter Mn-induced LH release in vivo. We 
also demonstrated that the blocking NOS did not alter Mn-induced LH release in vivo, 
nor did it alter Mn-induced LHRH release in vitro. Importantly, at doses of 50 and 
100µM, Mn did not induce total NO2-, a marker of NO production, yet these doses were 
capable of stimulating LHRH release. Only the 250µM dose caused increased NO2- 
accumulation. Thus, taken together these results suggest that low doses of Mn do not 
induce LHRH release after first acting to stimulate NOS/NO. Conversely, ODQ, a 
specific blocker of sGC, dose dependently inhibited the release of LHRH induced by 
Mn, demonstrating that GC is the site of Mn action to facilitate LHRH secretion. 
Furthermore, Mn stimulates directly the release of cGMP and LHRH from the same 
MBH tissue, and finally, a downstream PKG inhibitor, KT5823, blocked Mn-induced 
LHRH release. Overall, these results demonstrate that the principal action of Mn is to 
facilitate activation of GC, subsequently stimulating the cGMP/ PKG pathway 
controlling LHRH secretion in prepubertal female rats. The fact that Mn can stimulate 
GC in prepubertal animals is supportive of an earlier report indicating that Mn is a 
natural element that is particularly important during development and capable of 
activating more than 50 enzyme systems, including GC and protein kinases 
(Wedler,1993). Furthermore, even though it has been known since the1970’s that the Mn 
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cation is the preferred cofactor for GC and that MnCl2 can increase GC activity either 
directly or as a co-factor with NO (Garbers, 1979; Murad, 1994), to our knowledge, the 
present report is the first to demonstrate a Mn stimulation of sGC in a physiological 
setting relevant to neuropeptide hormone secretion. 
      The results generated by this study further indicate that Mn, through its ability to 
stimulate prepubertal LHRH/ LH secretion, may contribute to events leading to puberty. 
The age at which normal puberty occurs depends on a complex series of events within 
the hypothalamus that culminate in the increased release of LHRH. This timely increase 
appears to require the interactive participation of neuronal circuitries and glial cells 
within the hypothalamus (Ojeda and Ubanski, 1994) which are likely influenced by 
specific metabolic signals, as well as genetic and environmental influences. Signals that 
can activate excitatory amino acid receptors (Nyberg et al., 1993; Urbanski and Ojeda 
1990; Gay and Plant, 1987), and the peptides, insulin-like growth factor-1 (Hiney et al., 
1996; Danilovich et al., 1999; Wilson, 1998), and kisspeptin (Navarro et al., 2004; 
Shahab et al., 2005) are all examples of influences capable of stimulating LHRH release 
and advancing signs of sexual maturity. We have indicated here, and in previous work 
(Pine et al., 2005), that Mn is an essential nutrient that can also stimulate LHRH/ LH 
release and advance puberty, suggesting that it may represent an important 
environmental component of the pubertal process.  
      Mn is able to enter the brain either through the cerebral vasculature or via the 
cerebral spinal fluid (CSF). The mechanism by which Mn crosses the blood brain barrier 
is not well understood, but apparently involves binding of the metal to transport systems 
 60
such as transferrin (Aschner and Aschner, 1990; Aschner and Aschner, 2000). As the 
blood levels of Mn rise, its influx into the CSF rises and entry across the choroid plexus 
becomes more important (Murphy et al., 1991). The preoptic area and hypothalamus, 
which are adjacent to the third ventricle, receive Mn from both capillaries and the CSF. 
It has been shown that Mn crosses the blood brain barrier over four times more 
efficiently in the young (Mena, 1974), and younger animals do not have the full capacity 
to eliminate the Mn (Fechter, 1999). Furthermore, the element accumulates in the 
hypothalamus (Deskin et al., 1980; Pine et al., 2005), and is known to be taken up by 
both neurons and glial cells (Tholey et al., 1990); thus, suggesting a possible role in 
neuronal/glial communications within the developing hypothalamus. 
       Evidence has been presented in recent years suggesting that puberty may be 
occurring at an earlier age, especially in females (Herman-Giddings et al., 1997; Parent 
et al., 2003). The cause of this apparent trend is not known, but pubertal onset before 8 
years of age in girls and 9.5 years in boys is considered precocious (Lee, 1996). The 
central form of precocious puberty is LHRH-dependent, and is characterized by 
hormonal changes similar to those occurring at the normal time of puberty. Importantly, 
in central precocious puberty there is a premature activation of the LHRH secretory 
system. In boys, this is usually accounted for by hypothalamic harmatomas, other CNS 
lesions, or familial disease with less that 10% considered idiopathic. Conversely, in girls, 
over 65% of the cases of precocious puberty are considered idiopathic. Thus far, 
research suggests that in addition to a possible action of Mn during normal pubertal 
events, a risk to certain individuals for precocious puberty could develop should they be 
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exposed to elevated levels of the element during the juvenile or early adolescent years. 
This possibility is supported by several lines of evidence. As mentioned above, we have 
shown that Mn acts centrally to stimulate LHRH secretion and it causes elevated 
gonadotropin and gonadal steroid levels, and can advance puberty in both sexes, 
although females appear to be more sensitive to low but elevated levels (Pine et al., 
2005; Lee et al., 2006). Environmental sources of Mn are abundant since it is found in 
water, food, soil and air, with some regions having higher levels than others, and some 
cultures consuming greater amounts in their diets than others. Infants and children have 
been classified as being more sensitive to Mn exposure (EPA, 2002), mainly because the 
minimum level of exposure is not well defined (Greger, 1999). We suggest that should 
moderately elevated levels of Mn accumulate in the hypothalamus too early in life and 
reach levels not normally attained until later, then a potential concern for precocious 
development may occur. Epidemiological research in children and experimental studies 
in primates may be able to further address this question. 
 In summary, our results clearly show that Mn can induce prepubertal LHRH 
secretion via a hypothalamic action to activate sGC, causing stimulation of the 
cGMP/PKG pathway. Because of this hypothalamic action, and the fact that Mn 
administration can advance puberty, we suggest that this essential nutrient is a potential 
environmental factor involved in the pubertal process.  
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 
This study is the first to show that Mn is capable of acting at the hypothalamus to 
stimulate the secretion of puberty related hormones and advance the time of puberty in 
animals. Specifically, our initial study using prepubertal female rats, showed in vitro that 
Mn induces luteinizing hormone releasing hormone (LHRH) secretion from nerve 
terminals in the basal hypothalamus, that the central administration of Mn increased 
luteinizing hormone (LH) release dose-dependently, and that this action was blocked by 
pretreatment with acyline, an LHRH receptor antagonist. Chronically, we demonstrated 
that low level Mn supplementation caused elevated levels of serum LH, follicle 
stimulating hormone (FSH), and estradiol (E2), and advanced vaginal opening (VO). 
Together, the results indicate a hypothalamic action of Mn to activate the female 
reproductive system at the time of puberty.  
The age at which the normal onset of puberty begins is variable and depends on a 
complex series of events within the hypothalamus that culminate in the increased 
secretion of LHRH. At puberty, the pituitary and gonad are capable of function at any 
age after a short period of exposure to LHRH (Lee 1996). LHRH secretion is minimal 
during juvenile and childhood development and thus, this system is down-regulated; 
however, when the secretion pattern of the peptide is enhanced, the onset of puberty 
begins.  
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The fact that this study shows that low doses of Mn can act centrally to elicit 
prepubertal LHRH/LH secretion is important, and it suggests a facilitative role of the 
metal at the time of puberty. These results also indicate that an early elevation of Mn 
could pose a risk for precocious sexual development. This may not necessarily mean 
high levels, but that if Mn accumulates in specific brain regions too early in life and 
reaches levels not normally attained until later, then a potential problem could arise. In 
this regard, Mn-induced activation of the LHRH releasing system early in childhood 
may place an individual at risk for precocious pubertal development.  
Puberty may be occurring at an earlier age especially in females, yet the cause of 
this trend is not known. The onset of puberty before age 8 in girls and 9.5 in boys is 
usually considered precocious (Lee 1996). The central form of precocious puberty is 
LHRH-dependent and characterized by hormonal changes similar to those that occur at 
the normal time of puberty. In the central form of puberty there is a premature activation 
of the LHRH pulse generator. In boys, this activation is usually accounted for by 
hypothalamic hamartomas, other central nervous system lesions, or familial disease with 
less than 10% being idiopathic. In girls, however, over 65% of the cases are considered 
idiopathic. There must be some underlying cause(s) and any substance that can act 
centrally to stimulate LHRH release could possibly be involved.  
Mn is able to enter the brain either through the cerebral vasculature or via the 
cerebral spinal fluid (CSF). Mn has been shown to cross the blood brain barrier over four 
times more efficiently in young animals, which do not have full capacity to eliminate 
this metal (Mena 1974), and is known to be taken up by both neurons and glial cells 
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(Tholey et al., 1990); thus, suggesting a possible role in neuronal/ glial communications 
within the developing hypothalamus. The mechanism of crossing the blood brain barrier 
is not completely understood, but likely involves binding of Mn to transport systems 
such as transferrin (Aschner and Aschner, 1990; Aschner, 2000). As the blood levels of 
Mn rise, its influx into the CSF rises and entry across the choroid plexus becomes more 
important (Murphy et al., 1991). The preoptic area (POA) and hypothalamus, which are 
adjacent to the third ventricle, receive Mn from both capillaries and the CSF. 
Importantly, this study revealed the accumulation of Mn in both of these brain regions 
that control reproductive function in immature females, further supporting the potential 
risk for developmental alterations caused by early Mn exposure.  
Knowing the effects of Mn on female development, a logical question was 
whether Mn could cause the same effects on the development of prepubertal male rats. 
In this regard, we showed that the acute action on LHRH/LH release, both in vivo and in 
vitro were similar to that which we described in females, although the dose required was 
somewhat higher. Chronically, the serum levels of LH, FSH, and testosterone were 
elevated after Mn supplemental treatment, and again, a higher dose was observed 
compared with females. It is well-known that LH facilitates spermatogenesis by 
stimulating production of testosterone, and both FSH and testosterone are capable of 
stimulating all phases of spermatogenesis (Simoni et al., 1999). Importantly, the present 
study showed that chronic, low level of Mn exposure advanced spermatogenesis as 
indicated by increased daily sperm production and efficiency of sperm production.  
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Comparing results from the male and female studies, we suggest a gender 
difference in responsiveness to Mn. A 10 mg/kg dose of Mn was effective in 
significantly elevating serum gonadotropins and advancing the time of vaginal opening 
in females, while a 25 mg/kg dose of Mn was required to significantly elevate serum 
gonadotropins and accelerate spermatogenesis in males. These results suggest that males 
are less sensitive to the hypothalamic effect of Mn than females. Male rats require higher 
level of Mn exposure and it appears to be due to gender differences in Mn metabolism; 
male rats clearing Mn two times faster than female rats (Zheng et al., 2000). Even 
though a greater oral dose of Mn was required for males, it is important to note that it 
was still much lower than doses shown to produce neurotoxicological effects in adult 
rats and primates (Newland 1999).  
Overall, our results clearly indicate that Mn is capable of acting within the 
hypothalamus to induce puberty related hormones, and to advance the timing of puberty 
in both sexes. Thus, it became important to discern the hypothalamic site and mechanism 
by which Mn acts to stimulate hypothalamic function at puberty. Therefore, we used 
both in vitro and in vivo methods to investigate the potential pathways that could be 
involved in Mn-stimulated LHRH secretion in prepubertal female rats.   
In this regard, we showed that blocking the N-methyl-DL- aspartic acid receptors 
(NMDA-R), the insulin-like growth factor-1 receptors (IGF1-R), or inhibiting nitric 
oxide synthase (NOS) was ineffective in altering Mn induced LHRH/LH release. Dose 
response, pharmacological blockade and nitrite (NO2-) assessments indicated that the 
lowest doses of Mn used stimulated LHRH release, but did not induce nitric oxide (NO) 
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production, while only the highest dose stimulated NO. Conversely, dose dependent 
inhibition of Mn-induced release of LHRH by ODQ, a specific blocker of soluble 
guanylyl cyclase (sGC), demonstrated that sGC is the site of this Mn action. 
Furthermore, the study showed that Mn stimulated the release of cyclic GMP (cGMP) 
and LHRH from the same medial basal hypothalamic (MBH) tissue, and a downstream 
protein kinase G (PKG) inhibitor, KT5823, blocked Mn-induced LHRH release. 
Collectively, these data demonstrate that the principal action of Mn is to facilitate 
activation of GC, subsequently stimulating the cGMP/PKG pathway controlling LHRH 
secretion in prepubertal female rats.  
Mn is a natural element that is particularly important during development and 
capable of activating more than 50 enzyme systems, including GC and protein kinases 
(Wedler, 1993). Importantly, even though it has been known since the1970’s that the Mn 
cation is the preferred cofactor for GC, and that MnCl2 can increase GC activity either 
directly or as a co-factor with NO (Garbers, 1979; Murad, 1994), the present study is the 
first to demonstrate a Mn stimulation of sGC in a physiological setting relevant to 
neuropeptide hormone secretion 
      The results generated by this study further support that Mn contributes to events 
leading to puberty by stimulating LHRH/LH secretion. As mentioned above, the age at 
which normal puberty begins depends on a complex series of events within the 
hypothalamus that culminate in the increased release of LHRH. This timely increase 
appears to require the interactive participation of neuronal circuitries and glial cells 
within the hypothalamus (Ojeda and Ubanski, 1994), which are likely influenced by 
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specific metabolic signals, as well as genetic and environmental influences. Signals that 
can activate excitatory amino acid receptors (Nyberg et al., 1993; Urbanski and Ojeda 
1990; Gay and Plant, 1987), and the peptides, insulin-like growth factor-1 (Hiney et al., 
1996; Danilovich et al., 1999; Wilson, 1998), and kisspeptin (Navarro et al., 2004; 
Shahab et al., 2005) are other examples of influences capable of stimulating LHRH 
release and advancing signs of sexual maturity. Our results suggest that Mn, through its 
ability to stimulate prepubertal LHRH release, may be an environmental factor, which 
may work in concert with the above signals, as well as with genetic factors to influence 
pubertal development.  
 In conclusion, our results clearly show that exposure to low levels of Mn during 
juvenile development can induce prepubertal LHRH/LH secretion at the hypothalamic 
level. The mechanism of Mn action is through activation of sGC, which causes 
stimulation of the cGMP/PKG pathway, resulting in the stimulated secretion of LHRH 
and thereby playing an early role in the pubertal process. Based on these results, we 
suggest that Mn may be an important environmental component of the pubertal process; 
however, should levels of this metal accumulate in the hypothalamus prior to the normal 
time of puberty, then this may put an individual at a higher risk for precocious pubertal 
development.  
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